Mucositis is a common complication of chemotherapy, radiotherapy and targeted agents. It
often affects compliance to anticancer therapies as it frequently causes schedule delays …

Oncologic treatments, such as curative radiotherapy and chemoradiation, for head and neck
cancer can cause long-term swallowing impairments (dysphagia) that negatively impact …

Earlier evidence has proven that probiotic supplements can reduce concurrent
chemoradiotherapy (CCRT)-induced oral mucositis (OM) in nasopharyngeal cancer (NPC) …

Oral pain due to cancer and associated treatments is common. The prevalence and severity
of oral cancer is high. Painful oral mucositis develops in head and neck cancer patients …

Background: Neuropathic pain (NP) in head and neck cancer (HNC) patients represents a
treatment challenge. Most studies investigating drugs against NP are conducted in patients …

In recent years oral mucosal injury has been increasingly recognized as an important toxicity
associated with mammalian target of rapamycin (mTOR) inhibitors, including in patients with …

Oral squamous cell carcinoma (OSCC) patients suffer from poor survival due to metastasis
or locoregional recurrence, processes that are both facilitated by perineural invasion (PNI) …

In many patients with cancer, chemotherapy-induced severe oral ulcerative mucositis
causes intractable pain, leading to delays and interruptions in therapy. However, the pain …

Background Cancer pain is a devastating condition. Pain in the orofacial region, may be
present as the single symptom of cancer or as a symptom of cancer in its later stages. This …

Objective To investigate the promote healing and analgesic effects of NAHAO® Brand
Nazhen oral antibacterial care solution (NAHAO® spray) on the 5-fluorouracil-induced oral …